Akt Kinase-Interacting Protein1, a Novel Therapeutic Target for Lung Cancer With EGFR-activating and Gatekeeper Mutations
Oncogene - United Kingdom
doi 10.1038/onc.2012.446
Full Text
Open PDFAbstract
Available in full text
Date
October 8, 2012
Authors
Publisher
Springer Science and Business Media LLC